An Appendix of Radionuclides Used in Targeted Alpha Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An Appendix of Radionuclides Used in Targeted Alpha Therapy

Published:2019-12 Issue:4 Volume:50 Page:S58-S65
ISSN:1939-8654
Container-title:Journal of Medical Imaging and Radiation Sciences
language:en
Short-container-title:Journal of Medical Imaging and Radiation Sciences

Author:

Ferrier Maryline G.,Radchenko Valery

Funder

Lawrence Livermore National Laboratory

U.S. Department of Energy

National Research Council Canada

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Reference40 articles.

1. Targeting the nucleus: an overview of auger-electron radionuclide therapy;Cornelissen;Curr Drug Discov Technol,2010

2. Alpha-emitters for immuno-therapy: a review of recent developments from chemistry to clinics;Huclier-Markai;Curr Top Med Chem,2012

3. Targeted alpha and beta radiotherapy: an overview of radiopharmaceutical and clinical aspects;Lacoeuille;Méd Nucl,2018

4. Alpha-emitters and targeted alpha therapy in oncology: from basic science to clinical investigations;Makvandi;Target Oncol,2018

5. Global comparison of targeted alpha vs targeted beta therapy for cancer: in vitro, in vivo and clinical trials;Marcu;Crit Rev Oncol Hematol,2018

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiolabeled Probes from Derivatives of Natural Compounds Used in Nuclear Medicine;Molecules;2024-09-08

2. Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer;Nature Reviews Urology;2024-08-07

3. Navigating through the coordination preferences of heavy alkaline earth metals: Laying the foundations for 223Ra- and 131/135mBa-based targeted alpha therapy and theranostics of cancer;Journal of Inorganic Biochemistry;2024-07

4. 225Ac-PSMA-617 Augmentation in High-Risk mCRPC Undergoing 177Lu-PSMA-617 Radioligand Therapy;Clinical Nuclear Medicine;2024-05-21

5. ²²⁵Ac/²¹³Bi radionuclide generators for the separation of ²¹³Bi towards clinical demands;Inorganic Chemistry Frontiers;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3